StemCells, Inc. (NASDAQ:STEM)

CAPS Rating: 2 out of 5

A biopharmaceutical company that operates in one segment, the development of novel cell-based therapeutics designed to treat human diseases and disorders.

Recs

0
Player Avatar HollowMountain (< 20) Submitted: 2/18/2011 4:33:19 AM : Outperform Start Price: $9.65 STEM Score: -90.78

I keep doing screens to find new ideas, and I always run into this one, I like the sector and the fundamentals aren't TOO bad. Plus with a possible first mover in a hyped sector, this could pop on speculation alone.

Featured Broker Partners


Advertisement